NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

That’s exactly why she said the Leuka operation would also be used for other business. You need to think like LP! SEC has no case.

“By opening this clinic, NWBO aims to alleviate capacity limitations and provide services not only for its own programs but also for external clients, potentially increasing revenue streams and operational efficiency.”

>>First off I think this idea of rejection and appeal is kind of crazy because of the April PR about the leukapheresis clinic. Putting that out while sitting on a rejection/appeal would be straight up misleading shareholders, which while definitely possible, is the kind of thing I think the SEC would actually care about a great deal. Also something that I think would leak.